Investing Profile

Peter Thompson

InvestorVC
Partner at Orbimed
orbimed.comBellevue, Washington
Photo of Peter Thompson, Partner at OrbiMed
Your Intro Paths to Peter Thompson

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Peter Thompson on

cb
Current Investing Position
OrbiMed Partner
Investment Range
$1M - $75.0M
Sweet Spot
$4.0M
Investments On Record
32
Current Fund Size
$18B

Peter Thompson is on these Sector & Stage Rankings

Peter Thompson's Investments On Record (17)

CompanyStageDateRound SizeTotal Raised
Ottimo Pharma
Series ADec 2024$140M
$140M
Co-investors: Mark Chin (Arix Bioscience)
Sionna Therapeutics
Series CMar 2024$180M
Series BApr 2022$110M
$290M
Co-investors: Bruce Booth (Atlas Venture)
Terremoto Biosciences
Series BNov 2023$180M
Series AMay 2022$75M
$250M
Co-investors: Kevin Koch (OrbiMed), Reid Huber (Third Rock Ventures), Jeffrey Tong (Third Rock Ventures)
ReCode Therapeutics
Series BSep 2023$50M
Series BOct 2021$80M
Series AMar 2020$80M
$210M
Co-investors: Ed Hurwitz (MPM Capital), Helen Kim (Vida Ventures), Rana Al-Hallaq (Pfizer Venture Investments), Kouki Harasaki (Bioluminescence Ventures)
Aspen Neuroscience
Series BMay 2022$150M
Series AApr 2020$70M
SeedDec 2019$7M
$230M
Co-investors: Jonathan Silverstein (OrbiMed), Doug Fisher (InterWest), Sam Altman
Carrot Fertility
Series CAug 2021$75M
$120M
Co-investors: Reid Christian (CRV), Jay Chen (Tiger Global Management), Arjun Sethi (Tribe Capital), Carl Byers (F-Prime Capital Partners), Sara Thomas Deshpande (Maven Ventures), Brad Flora (Y Combinator), Terrence Rohan (Otherwise Fund), Stephanie Palmeri (NextView Ventures), Dafina Toncheva (U.S. Venture Partners (USVP)), Chloe Sladden (#ANGELS (Hashtag ANGELS))
Janux Therapeutics
Series BApr 2021$130M
Series AMar 2021$56M
$180M
Co-investors: Jay Lichter (Avalon Ventures), Jake Simson (RA Capital)
Edgewise Therapeutics
Series CDec 2020$95M
Series BSep 2019$50M
$150M
Co-investors: Jonathan Root (U.S. Venture Partners (USVP))